Collegium Pharmaceutical, Inc. (COLL) Stock Analysis

Free AI-powered analysis and research for Collegium Pharmaceutical, Inc. stock

Sector: Healthcare

Analyze Collegium Pharmaceutical, Inc. (COLL) Stock

Collegium Pharmaceutical, Inc. (COLL) is a leading company in the Healthcare sector. Use StockIQ's free analysis tool to get comprehensive insights into COLL stock performance, technical indicators, and AI-powered trading recommendations.

Get instant AI-powered analysis including technical indicators, fundamental analysis, risk assessment, and trading insights for Collegium Pharmaceutical, Inc. stock.

Analyze COLL Now →

📰 Latest Update

Collegium Pharmaceutical (COLL) Q2 2026 Earnings Call Transcript

Thu, August 13, 2026 at 12:29 PM UTC 3 min read

Collegium Pharmaceutical (COLL) reported its Q2 2026 earnings, showcasing a significant increase in revenue driven by strong sales of its pain management products. The company's successful launch of new formulations and expansion into additional markets highlight its growth potential. For investors, this performance underscores COLL's strategic positioning in the pharmaceutical sector, suggesting a positive outlook for future profitability and market share expansion.

Read full article →